(3aS,3bS,9aR,9bR,11aS)-5,6,9a,11a-tetramethyl-7-oxo-N-[(1-phenylbenzimidazol-2-yl)methyl]-2,3,3a,3b,4,8,9,9b,10,11-decahydro-1H-indeno[5,4-f]quinoline-1-carboxamide

C35H42N4O2 — CID 69053946

IUPAC(3aS,3bS,9aR,9bR,11aS)-5,6,9a,11a-tetramethyl-7-oxo-N-[(1-phenylbenzimidazol-2-yl)methyl]-2,3,3a,3b,4,8,9,9b,10,11-decahydro-1H-indeno[5,4-f]quinoline-1-carboxamide
SMILESCC1=C2N(C)C(=O)CC[C@]2(C)[C@@H]2CC[C@]3(C)C(C(=O)NCc4nc5ccccc5n4-c4ccccc4)CC[C@H]3[C@@H]2C1
InChIInChI=1S/C35H42N4O2/c1-22-20-24-25-14-15-27(34(25,2)18-16-26(24)35(3)19-17-31(40)38(4)32(22)35)33(41)36-21-30-37-28-12-8-9-13-29(28)39(30)23-10-6-5-7-11-23/h5-13,24-27H,14-21H2,1-4H3,(H,36,41)/t24-,25-,26+,27?,34-,35+/m0/s1
InChIKeyOOMMYOGRJDWMQX-PSSQLLDJSA-N
MW550.75 g/mol
LogP6.64
Rot. Bonds4

About (3aS,3bS,9aR,9bR,11aS)-5,6,9a,11a-tetramethyl-7-oxo-N-[(1-phenylbenzimidazol-2-yl)methyl]-2,3,3a,3b,4,8,9,9b,10,11-decahydro-1H-indeno[5,4-f]quinoline-1-carboxamide

(3aS,3bS,9aR,9bR,11aS)-5,6,9a,11a-tetramethyl-7-oxo-N-[(1-phenylbenzimidazol-2-yl)methyl]-2,3,3a,3b,4,8,9,9b,10,11-decahydro-1H-indeno[5,4-f]quinoline-1-carboxamide (PubChem CID 69053946) has the molecular formula C35H42N4O2 and a molecular weight of 550.75 g/mol. Its IUPAC name is (3aS,3bS,9aR,9bR,11aS)-5,6,9a,11a-tetramethyl-7-oxo-N-[(1-phenylbenzimidazol-2-yl)methyl]-2,3,3a,3b,4,8,9,9b,10,11-decahydro-1H-indeno[5,4-f]quinoline-1-carboxamide.

Molecular Properties

Compound Name(3aS,3bS,9aR,9bR,11aS)-5,6,9a,11a-tetramethyl-7-oxo-N-[(1-phenylbenzimidazol-2-yl)methyl]-2,3,3a,3b,4,8,9,9b,10,11-decahydro-1H-indeno[5,4-f]quinoline-1-carboxamide
PubChem CID69053946
Molecular FormulaC35H42N4O2
Molecular Weight550.75 g/mol
Exact Mass550.33
IUPAC Name(3aS,3bS,9aR,9bR,11aS)-5,6,9a,11a-tetramethyl-7-oxo-N-[(1-phenylbenzimidazol-2-yl)methyl]-2,3,3a,3b,4,8,9,9b,10,11-decahydro-1H-indeno[5,4-f]quinoline-1-carboxamide
SMILESCC1=C2N(C)C(=O)CC[C@]2(C)[C@@H]2CC[C@]3(C)C(C(=O)NCc4nc5ccccc5n4-c4ccccc4)CC[C@H]3[C@@H]2C1
InChIInChI=1S/C35H42N4O2/c1-22-20-24-25-14-15-27(34(25,2)18-16-26(24)35(3)19-17-31(40)38(4)32(22)35)33(41)36-21-30-37-28-12-8-9-13-29(28)39(30)23-10-6-5-7-11-23/h5-13,24-27H,14-21H2,1-4H3,(H,36,41)/t24-,25-,26+,27?,34-,35+/m0/s1
InChIKeyOOMMYOGRJDWMQX-PSSQLLDJSA-N
XLogP6.64
TPSA67.23 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds4
Heavy Atoms41
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500550.75
LogP ≤ 56.64
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Analyze (3aS,3bS,9aR,9bR,11aS)-5,6,9a,11a-tetramethyl-7-oxo-N-[(1-phenylbenzimidazol-2-yl)methyl]-2,3,3a,3b,4,8,9,9b,10,11-decahydro-1H-indeno[5,4-f]quinoline-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3aS,3bS,9aR,9bR,11aS)-5,6,9a,11a-tetramethyl-7-oxo-N-[(1-phenylbenzimidazol-2-yl)methyl]-2,3,3a,3b,4,8,9,9b,10,11-decahydro-1H-indeno[5,4-f]quinoline-1-carboxamide?
The IUPAC name of (3aS,3bS,9aR,9bR,11aS)-5,6,9a,11a-tetramethyl-7-oxo-N-[(1-phenylbenzimidazol-2-yl)methyl]-2,3,3a,3b,4,8,9,9b,10,11-decahydro-1H-indeno[5,4-f]quinoline-1-carboxamide (CID 69053946) is (3aS,3bS,9aR,9bR,11aS)-5,6,9a,11a-tetramethyl-7-oxo-N-[(1-phenylbenzimidazol-2-yl)methyl]-2,3,3a,3b,4,8,9,9b,10,11-decahydro-1H-indeno[5,4-f]quinoline-1-carboxamide.
What is the SMILES notation for (3aS,3bS,9aR,9bR,11aS)-5,6,9a,11a-tetramethyl-7-oxo-N-[(1-phenylbenzimidazol-2-yl)methyl]-2,3,3a,3b,4,8,9,9b,10,11-decahydro-1H-indeno[5,4-f]quinoline-1-carboxamide?
The canonical SMILES for (3aS,3bS,9aR,9bR,11aS)-5,6,9a,11a-tetramethyl-7-oxo-N-[(1-phenylbenzimidazol-2-yl)methyl]-2,3,3a,3b,4,8,9,9b,10,11-decahydro-1H-indeno[5,4-f]quinoline-1-carboxamide is CC1=C2N(C)C(=O)CC[C@]2(C)[C@@H]2CC[C@]3(C)C(C(=O)NCc4nc5ccccc5n4-c4ccccc4)CC[C@H]3[C@@H]2C1.
What is the InChIKey of (3aS,3bS,9aR,9bR,11aS)-5,6,9a,11a-tetramethyl-7-oxo-N-[(1-phenylbenzimidazol-2-yl)methyl]-2,3,3a,3b,4,8,9,9b,10,11-decahydro-1H-indeno[5,4-f]quinoline-1-carboxamide?
The InChIKey is OOMMYOGRJDWMQX-PSSQLLDJSA-N. The full InChI is InChI=1S/C35H42N4O2/c1-22-20-24-25-14-15-27(34(25,2)18-16-26(24)35(3)19-17-31(40)38(4)32(22)35)33(41)36-21-30-37-28-12-8-9-13-29(28)39(30)23-10-6-5-7-11-23/h5-13,24-27H,14-21H2,1-4H3,(H,36,41)/t24-,25-,26+,27?,34-,35+/m0/s1.
What are the key properties of (3aS,3bS,9aR,9bR,11aS)-5,6,9a,11a-tetramethyl-7-oxo-N-[(1-phenylbenzimidazol-2-yl)methyl]-2,3,3a,3b,4,8,9,9b,10,11-decahydro-1H-indeno[5,4-f]quinoline-1-carboxamide?
(3aS,3bS,9aR,9bR,11aS)-5,6,9a,11a-tetramethyl-7-oxo-N-[(1-phenylbenzimidazol-2-yl)methyl]-2,3,3a,3b,4,8,9,9b,10,11-decahydro-1H-indeno[5,4-f]quinoline-1-carboxamide has a molecular weight of 550.75 g/mol, XLogP of 6.64, 4 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (3aS,3bS,9aR,9bR,11aS)-5,6,9a,11a-tetramethyl-7-oxo-N-[(1-phenylbenzimidazol-2-yl)methyl]-2,3,3a,3b,4,8,9,9b,10,11-decahydro-1H-indeno[5,4-f]quinoline-1-carboxamide is sourced from PubChem (CID 69053946), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).